Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Van

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Brain Sciences|September 27, 2025
Targeting Fear of Cancer Recurrence with Internet-Based Emotional Freedom Techniques (iEFT) and Mindfulness Meditation Intervention (iMMI) (BGOG-gyn1b/REMOTE)Laura Tack, Lore Mertens, Marte Vandeweyer, et al.
Vaccines|March 26, 2022
Predictors of COVID-19 Vaccine Hesitancy in South African Local Communities: The VaxScenes StudyPatrick D M C Katoto, Saahier Parker, Nancy Coulson, et al.
PLOS Global Public Health|September 5, 2023
Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling studyMaitreyi Sahu, Cara J Bayer, D Allen Roberts, et al.
Acta Oncologica (Stockholm, Sweden)|July 30, 2025
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?Alexander Decruyenaere, Gennigens Christine, Rottey Sylvie, et al.
BMC Geriatrics|November 19, 2022
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter studyCindy Kenis, Lore Decoster, Johan Flamaing, et al.
The Lancet. Global Health|August 9, 2014
Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trialThomas J Coates, Michal Kulich, David D Celentano, et al.
Journal of Geriatric Oncology|September 9, 2022
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational studyGlen Meert, Cindy Kenis, Koen Milisen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 22, 2022
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology GroupIgnace Vergote, Els Van Nieuwenhuysen, Stefanie De Waele, et al.
Cancers|July 14, 2023
End-of-Life Care in the Last Three Months before Death in Older Patients with Cancer in Belgium: A Large Retrospective Cohort Study Using Data LinkageVictoria Depoorter, Katrijn Vanschoenbeek, Lore Decoster, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2008
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)Warren D Hirst, Terrance H Andree, Suzan Aschmies, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Brain Sciences|September 27, 2025
Targeting Fear of Cancer Recurrence with Internet-Based Emotional Freedom Techniques (iEFT) and Mindfulness Meditation Intervention (iMMI) (BGOG-gyn1b/REMOTE)Laura Tack, Lore Mertens, Marte Vandeweyer, et al.
Vaccines|March 26, 2022
Predictors of COVID-19 Vaccine Hesitancy in South African Local Communities: The VaxScenes StudyPatrick D M C Katoto, Saahier Parker, Nancy Coulson, et al.
PLOS Global Public Health|September 5, 2023
Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling studyMaitreyi Sahu, Cara J Bayer, D Allen Roberts, et al.
Acta Oncologica (Stockholm, Sweden)|July 30, 2025
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?Alexander Decruyenaere, Gennigens Christine, Rottey Sylvie, et al.
BMC Geriatrics|November 19, 2022
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter studyCindy Kenis, Lore Decoster, Johan Flamaing, et al.
The Lancet. Global Health|August 9, 2014
Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trialThomas J Coates, Michal Kulich, David D Celentano, et al.
Journal of Geriatric Oncology|September 9, 2022
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational studyGlen Meert, Cindy Kenis, Koen Milisen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 22, 2022
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology GroupIgnace Vergote, Els Van Nieuwenhuysen, Stefanie De Waele, et al.
Cancers|July 14, 2023
End-of-Life Care in the Last Three Months before Death in Older Patients with Cancer in Belgium: A Large Retrospective Cohort Study Using Data LinkageVictoria Depoorter, Katrijn Vanschoenbeek, Lore Decoster, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2008
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)Warren D Hirst, Terrance H Andree, Suzan Aschmies, et al.
Pageof 18